Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
A new and upgraded approach to the diseased states and wellness, and to re-shape tomorrow’s healthcare whilst doing it today, resulted in a new global trend in the healthcare services, namely, Personalized and Precision Medicine (PPM). PPM as a Unique Entity demonstrating a [....] » Read More
Keynote Presentation (In-Person)
The unprecedented rise in global population has intensified the need for safe, effective, and reversible contraceptive strategies to mitigate the far-reaching consequences of overpopulation. In recent decades, immunocontraception has emerged as a promising and biologica [....] » Read More
Oral Presentation (In-Person)
Biodesigners, biotechnologists and biomanufacturers are beginning to realize the promise of personalized and precision medicine (PPM), translating to direct benefit to patients or persons-at-risk. Both PPM, personalized vaccinomics and nanobiotechnologies are being integrated int [....] » Read More
Oral Presentation (In-Person)
Background: Infectious bronchitis virus (IBV) remains one of the most challenging pathogens affecting poultry health worldwide, particularly in regions where multiple genotypes co-circulate. In Egypt, the emergence and persistence of Variant 2–like strains (GI-23 lineage) a [....] » Read More
Oral Presentation (In-Person)
Background and objectives: Leukemia cell lines of Southeast Asian origin remain extremely rare in international biorepositories, and personalized neoantigen vaccines for hematologic malignancies are still barely implemented in middle-income countries. This study aimed to (i) gene [....] » Read More
Oral Presentation (In-Person)
Title: One health approaches to echinococcosis control: The role of vaccines
Background: Echinococcosis (hydatid disease) is a neglected zoonosis caused by Echinococcus granulosus and Echinococcus multilocularis, affecting over one million people globally and causing annual economic losses of approximately $3 billion. The disease cycle involves definitive [....] » Read More
Oral Presentation (In-Person)
Vaccine hesitancy: We do have a lot of issues from the community which make them hesitant towards vaccination process, includes disinformation about the vaccination spread by the community instigators play important role in this regards apart from that we do have a lot of re [....] » Read More
Oral Presentation (In-Person)
Title: Evaluation of the serological response after foot-and-mouth disease vaccination in Pakistan
Among viral diseases, Foot and Mouth Disease is a highly contagious, economically important disease of cloven-hoofed animals caused by a virus of the genus Aphthovirus, family Picornaviridae. A total of 12 calves of about one year old with proper tags were selected for the study. [....] » Read More
Oral Presentation (In-Person)
Title: Deep learning prediction of antigen–epitope immunogenicity for peptide vaccine design
Background: Peptide-based vaccines rely on the identification of antigenic epitopes capable of inducing strong immune responses. However, predicting immunogenic peptide sequences remains challenging due to the complex interaction between amino-acid composition, structural feature [....] » Read More
Oral Presentation (In-Person)
Title: Machine learning–guided identification of stable mRNA vaccine sequence designs
Background: Messenger RNA vaccines require precise sequence engineering to achieve optimal translational efficiency and molecular stability. Variations in nucleotide composition, secondary structure formation, and codon usage can significantly influence mRNA degradation rates and [....] » Read More
Oral Presentation (In-Person)
Background: COVID-19 vaccination remains a key strategy for reducing SARS-CoV-2 transmission and protecting high-risk populations. In resource-limited settings such as the Democratic Republic of Congo (DRC), improving vaccination coverage and addressing vaccine safety concerns ar [....] » Read More
Oral Presentation (In-Person)
Background: Antenatal care (ANC) and childhood immunization are central components of the maternal and child health continuum, yet their linkages within routine health systems remain insufficiently documented. Understanding how ANC performance aligns with immunization outcomes at [....] » Read More
Oral Presentation (In-Person)
Background: Climate change poses an increasing threat to healthcare systems, particularly vaccine cold chain management in low- and middle-income countries. Rising temperatures, erratic weather patterns, power interruptions, and extreme climatic events can compromise vaccine [....] » Read More
Oral Presentation (In-Person)
Background: Large migration flows between the Cambodian Thai borders for economic opportunities pose difficulties to provide and track immunizations among children of migrant worker communities, one of the four types of zero-dose communities in Cambodia. These children are often [....] » Read More
Oral Presentation (In-Person)
Background: Coronavirus Disease (COVID-19) is a global health emergency caused by SARS-CoV-2. Vaccination is a key prevention and control strategy. Ethiopia began COVID-19 vaccination in March 2021, but data on vaccine effectiveness remain limited, particularly in African countri [....] » Read More
Poster Presentation (In-Person)
Influenza is a highly contagious respiratory illness caused by influenza viruses, which remains a persistent challenge on global health. Vaccination is the most effective intervention to mitigate the public health burden caused by pandemic or endemic influenza. Compared to conven [....] » Read More
Poster Presentation (In-Person)
Title: Enzyme-free electrochemical strategy for mRNA vaccine detection
Tumor mRNA vaccines have demonstrated increasing potential in immunotherapy. With the advancement of vaccine development, monitoring in vivo levels and pharmacokinetic profiles is becoming essential. However, existing detection techniques often require large sample volumes and fa [....] » Read More
Poster Presentation (In-Person)
Title: How does COVID-19 disrupt immune homeostasis and its association with multiple system diseases?
Background: The immunopathological events and immune residues induced by COVID-19, particularly lymphocyte damage, play a central role in the pathogenesis of Long COVID. Identifying easy-to-detect biomarkers is crucial for understanding the persistence of symptoms. Objective: [....] » Read More
Keynote Presentation (Virtual)
For meeting the financial, quality and safety challenges as well as expectations of the patients, health and social care systems around the globe currently undergo a transformation towards personalized, preventive, predictive, participative precision medicine (5PM), supported by [....] » Read More
Oral Presentation (In-Person)
Title: Viral proteins activating PKA as an antiviral vaccine target
Viral infections like HIV and Ebola have created a link to the intracellular stress system via the cAMP-PKA pathway. This allows the virus to suppress T-helper cell activation and interferon signaling, while simultaneously using PKA to boost its replication in the case of Ebola i [....] » Read More
Oral Presentation (Virtual)
Title: Modular protein nanorings for next-generation immunoengineering
Immune interventions remain constrained by limited nanoscale control over how antigens and immune signals are presented, creating an immunoengineering bottleneck that impacts both communicable diseases (e.g., rapidly evolving influenza) and non-communicable diseases (e.g., Parkin [....] » Read More
Oral Presentation (Virtual)
Title: Autoimmunity after Covid-19: Mechanism, clinical evidence and emerging directions
Background: Since the emergence of SARS-CoV-2, increasing evidence has linked COVID-19 to the development of autoimmune phenomena ranging from transient autoantibody production to chronic, clinically significant autoimmune disease. Proposed mechanisms include molecular mimicry, b [....] » Read More
Oral Presentation (Virtual)
Background: The widespread implementation of heterologous COVID-19 vaccination strategies has substantially improved vaccine-induced protection against SARS-CoV-2. However, concerns regarding the potential induction of autoantibodies associated with autoimmune diseases and cancer [....] » Read More
Oral Presentation (Virtual)
Title: Subunit nasal vaccines: Overcoming barriers to innovation
Introduction: The development of mucosal vaccines has historically been limited by the lack of suitable adjuvants and concerns about potential neurotoxic effects. Prior to COVID-19, only one mucosal vaccine was commercially available. The accelerated technological progress and re [....] » Read More
Oral Presentation (Virtual)
Title: The impact of four pro- and anti-vaccine myths on vaccine feasibility
During a three-year (2021-2024) intensive study on "Are intramuscularly injectable vaccines' feasible to stop respiratory-based pathogens?" to determine the feasibility of such mode of vaccination, gathering 3+2 experiment-clinical case meta data, literature review, [....] » Read More
Oral Presentation (Virtual)
Title: Vaccine acceptance and health seeking behaviour the way forward
Vaccines are biological agents which provide active acquired immunity against infectious diseases. Agents in vaccines have similar properties with the micro-organism which causes the disease. Benefits of vaccination cannot be over emphasized as it is most cost-effective strategy [....] » Read More
Oral Presentation (Virtual)
Title: Immune memory based classification of human herd [IMCHH]
Individual and population/herd immunity are at most depend on the nature of effector cells on first encounter and immune memory cells on re-infection or boost vaccination. The present opinion paper tempts to propose human herd classification on the bases of memory immune ce [....] » Read More
© 2026 Mathews International LLC. All rights reserved.
